licensing agreement Exact Sciences Projects up to $475M in Q4 Revenues, Acquires Testing Lab, Inks Licensing Deal The approximately 2 percent increase over Q4 2020 results beat analysts' expectations, and the acquisition news heralds market expansion into hereditary cancer testing. Mainz Biomed Licenses mRNA Biomarkers for Colorectal Cancer Mainz said it will potentially integrate the biomarkers into its ColoAlert detection test for colorectal cancer. Baylor Genetics, SRL Ink Clinical Sequencing Tech Transfer Agreement Under the agreement, Baylor Genetics will transfer its clinical-grade whole-genome and whole-exome sequencing technology to SRL beginning in 2022. EpiCypher Licenses Chromatin Profiling Technologies From Fred Hutchinson Cancer Center The technologies, licensed co-exclusively, can be used to study histone post-translational modifications and chromatin-associated proteins. RNA Disease Diagnostics Licenses RNA Lateral Flow Tech for At-Home SARS-CoV-2 Test The company said the technology does not require nucleic acid amplification or isolation and can detect SARS-CoV-2 as effectively as PCR-based methods. Oct 12, 2021 Inscripta Licenses MAD7 CRISPR Nuclease to Hunterian Medicine Oct 6, 2021 MilliporeSigma Licenses CRISPR-Cas9 Technology to Cellecta Sep 13, 2021 Immunovia, JW BioScience Ink Licensing Agreement for Early Pancreatic Cancer Detection Biomarkers Aug 17, 2021 ERS Genomics Licenses CRISPR-Cas9 Portfolio to Cellular Engineering Technologies Jul 27, 2021 ERS Genomics Licenses CRISPR IP to Japan SLC Jul 1, 2021 ERS Genomics Licenses CRISPR IP to Nippon Gene Jun 7, 2021 ERS Genomics Licenses CRISPR IP to GenOway Jun 3, 2021 Crown Bioscience Licenses Cell Line Portfolio From NCI, ATCC May 21, 2021 Guardant Health to License IP to Foundation Medicine for $25M, Royalties Under Settlement Agreement May 20, 2021 Dutch Seed Firm Bejo Takes License to Corteva Agriscience, Broad Institute CRISPR IP May 12, 2021 ERS Genomics Licenses CRISPR Patents to GenScript Biotech May 11, 2021 Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests May 10, 2021 TellBio Raises $5M in Series A Round, Inks Deals With Genetron, ARUP for Liquid Biopsy Platform May 4, 2021 Phenomix, Mayo Clinic Ink Licensing Deal for Obesity Phenotype Blood Test May 4, 2021 Harvard Licenses Nasal Swab Collection Tech to Rhinostics May 3, 2021 Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk Apr 29, 2021 Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays Apr 21, 2021 Sherlock Bio Foundation Licenses CRISPR Tech to Cooper International, United PPE for COVID-19 Tests Apr 19, 2021 ERS Genomics Licenses CRISPR Patents to Nuvisan Mar 10, 2021 ERS Genomics Licenses CRISPR Patents to Setsuro Tech Load More Breaking News Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering The Scan Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there. Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.